ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ngµç×ÓÓÎÏ·Á¥ÊôµÚ°ËÒ½Ôº»Æ»Ô½ÌÊÚÍŶӷ¢Ã÷³¤ÊÙÂѰ×SIRT6ÖÎÁÆÑª¹Ü¸Æ»¯µÄÐÂDZÄÜ

¸å¼þȪԴ£ºÁ¥ÊôµÚ°ËÒ½Ôº ±à¼­£ºÖ£Áú·É¡¢¡¢¡¢Íõ¶¬Ã· ÔĶÁÁ¿£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±£ºÀèÎÄÐÅ£©11ÔÂ18ÈÕ£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚ°ËÒ½ÔºÐÄѪ¹ÜÄڿƻƻԽÌÊÚÍŶÓÔÚJournal of Clinical Investigation£¨IF=14.808£©ÉϽÒÏþÁËÌâΪ¡°SIRT6 protects vascular smooth muscle cell from osteogenic transdifferentiation via Runx2 in chronic kidney disease¡±µÄÎÄÕ£¬¸ÃÎÄ̽ÌÖÁËSIRT6ÔÚCKDËùÖÂѪ¹Ü¸Æ»¯ÖеÄ×÷Óü°·Ö×Ó»úÖÆ¡£

Ѫ¹Ü¸Æ»¯£¨Vascular Calcification£¬VC£©ÌØÊâÊÇѪ¹ÜÖÐĤ¸Æ»¯ÔÚÂýÐÔÉöÔಡ£¨Chronic Kidney Disease£¬CKD£©»¼ÕßÖкÜÊÇÆÕ±é£¬Ò²ÊÇCKDÐÄѪ¹ÜÊÂÎñ¸ß·¢µÄÖ÷ÒªÔªÐ×£¬Ò»µ©·ºÆðÍùÍùÒâζ׎ϲîµÄÔ¤ºó¡£È»¶ø£¬Æù½ñΪֹ£¬Æä·¢²¡»úÖÆÈÔ²»ÇåÎú£¬ÁÙ´²ÉÏȱ·¦ÓÐÓõÄÖÎÁÆ·½°¸¡£

Sirtuins (SIRTs)ÊÇÒ»ÖÖÊØ¾ÉµÄNAD+ÒÀÀµµÄÂѰ×È¥ÒÒõ £»¯Ã¸£¬¶ÔÐàÂõºÍ´úлÐÔ¼²²¡Óб £»¤×÷Ó㬱»ÒÔΪÊÇÐÄѪ¹Ü¼²²¡µÄÖ÷Òª°Ðµã¡£ËüÃÇ¿ÉÒÔά³ÖÄÚÆ¤Ï¸°ûµÄÎÈ̬¹¦Ð§£¬ÑÓ»ºÑª¹ÜÐàÂõ£¬± £»¤Ðļ¡Ï¸°û·ÀÖ¹Ðļ¡Ï¸°û·Ê´ó¡£SIRTsÔÚCKDÏà¹ØµÄÐÄѪ¹Ü¼²²¡ÖÐÒ²Óб £»¤×÷Ó㬵«ÆäÔÚѪ¹Ü¸Æ»¯ÖеÄ×÷Óü°»úÖÆÈÔÓдýÃ÷È·¡£³É¹Çϸ°ûÌØÒìÐÔת¼Òò×Ó2 (runt-related transcription factor 2,RUNX2£©ÊÇÒ»ÖֳɹǷֻ¯ÌØÒìÐÔת¼Òò×Ó, Äܹ»µ÷¿ØÖÚ¶à»ùÒòµÄת¼£¬¶Ô³É¹Çϸ°ûµÄ·Ö»¯ºÍÈí¹Çϸ°ûµÄ³ÉÊìÆðµ½ÖÁ¹ØÖ÷ÒªµÄ×÷Óá£

×÷ÕßÊ×ÏÈ´ÓÁÙ´²½Ç¶ÈÈëÊÖ£¬·¢Ã÷°éÓÐѪ¹Ü¸Æ»¯µÄCKD²¡ÈËÍâÖÜѪµ¥¸öºËϸ°ûÖеÄSIRT6 mRNAˮƽÒÔ¼°×Ô¶¯Âö×éÖ¯SIRT6ÂѰ×ˮƽÏÔÖøµÍÓÚ²»°éÓÐѪ¹Ü¸Æ»¯µÄCKD²¡ÈË£¬Í¬Ê±SIRT6µÄ±í´ïˮƽÓë¸Æ»¯AgatstonÆÀ·Ö³Ê¸ºÏà¹Ø£º¸Æ»¯ÆÀ·ÖÔ½¸ßµÄ»¼ÕßSIRT6µÄ±í´ïˮƽԽµÍ¡£Ëæºó£¬×÷Õß¹¹½¨¸ßÏÙàÑßʸßÁ×ÒûʳCKDСÊóÄ£×ÓÓë5/6ÉöÇгýÊõCKDÄ£×ÓÀ´ÓÕµ¼Ñª¹Ü¸Æ»¯£¬Ð§¹ûÏÔʾ¸Æ»¯Ð¡Êó×Ô¶¯ÂöSIRT6±í´ïˮƽÏÔÖø½µµÍ¡£

ΪÁË̽ÌÖSIRT6ÔÚѪ¹Ü¸Æ»¯ÖеÄ×÷Óã¬×÷ÕßÖÆ±¸ÁËSIRT6ת»ùÒò£¨SIRT6-Tg£©Ð¡Êó£¬ÒÔ¼°¹¹½¨ÁËѪ¹Üƽ»¬¼¡ÌØÒìÐÔSIRT6ÇüõAAV-2ÏÙÏà¹Ø²¡¶¾£¬Í¬Ê±ÌáÈ¡ÁËСÊóÔ­´úѪ¹Üƽ»¬¼¡Ï¸°û£¨VSMCs£©¡£Í¨¹ýÌåÄÚÓëÌåÍâ¹ý±í´ïÓëÇõÍSIRT6£¬Ö¤Êµ¹ý±í´ïSIRT6Äܹ»Ôڸƻ¯´Ì¼¤Ìõ¼þÏÂïÔÌ­×Ô¶¯Âö×éÖ¯ÓëVSMCsµÄ¸ÆÑγÁ»ý£¬Æðµ½± £»¤×÷Óà £»¶øÇüõSIRT6Ôò»á¼ÓÖØÑª¹Ü¸Æ»¯¡£

VSMCsµÄ³É¹Ç·Ö»¯ÔÚѪ¹Ü¸Æ»¯ÖÐÆðµ½ºÜÊÇÖ÷ÒªµÄ×÷Óã¬ÎªÁ˽øÒ»²½Ì½ÌÖSIRT6µ÷¿Ø¸Æ»¯µÄ»úÖÆ£¬×÷Õß¼ì²âÁ˹ý±í´ïÓëÇõÍSIRT6Ö®ºó£¬Ò»Ð©³É¹Ç·Ö»¯ÓëËõ¶Ì±íÐͱê¼ÇÂѰ׵ıí´ïת±ä£¬Ð§¹ûÏÔʾ¹ý±í´ïSIRT6Äܹ»ÒÖÖÆVSMCsµÄ³É¹Ç·Ö»¯¡£Runx2ÊÇÖ÷ÒªµÄ³É¹ÇÒò×Ó£¬SIRT6-TgСÊóÖÐRunx2ÂѰױí´ï½µµÍ£¬¶ø¹ý±í´ïRunx2ºóÄܹ»²¿·ÖÏ÷ÈõSIRT6µÄ± £»¤×÷Óã¬Òò¶ø×÷ÕßÍÆ²âSIRT6¿ÉÄÜͨ¹ýµ÷¿ØRunx2À´Ê©Õ¹ÆäÔÚѪ¹Ü¸Æ»¯Öеı £»¤×÷Óá£Co-IPʵÑé֤ʵ£¬SIRT6ÓëRunx2Ö®¼ä±£´æÏ໥×÷Ó᣶ÔRunx2µÄÒÒõ £»¯Ë®Æ½¾ÙÐмì²â·¢Ã÷£¬SIRT6¹ý±í´ïÄܹ»ïÔÌ­Runx2µÄÒÒõ £»¯Ë®Æ½£¬ÇõÍSIRT6ÔòÄÜÔöÌíRunx2µÄÒÒõ £»¯£¬Åú×¢SIRT6Äܹ»Í¨ÒÑÍùÒÒõ £»¯Runx2À´ÒÖÖÆÆ½»¬¼¡Ï¸°ûµÄ³É¹Ç·Ö»¯¡£¹ý±í´ïSIRT6Äܹ»½µµÍRunx2µÄÂѰ×ÎȹÌÐÔ£¬½øÒ»²½µÄʵÑé֤ʵSIRT6Äܹ»Í¨¹ý·ºËØ-ÂѰ×øÌå;¾¶½µ½âRunx2¡£

ÃâÒßÓ«¹âЧ¹ûÏÔʾ£¬¹ý±í´ïSIRT6µÄVSMCsÔÚ¸ßPi´Ì¼¤Ï£¬Ï¸°ûÖÊÖеÄRunx2ÏÔ×ŶàÓÚϸ°ûºË£¬ÌáÐÑSIRT6¿ÉÄÜÓ°ÏìÁËRunx2µÄϸ°ûÄÚ¶¨Î»¡£Exportin-1£¨XPO1£©ÔÚÂѰ׺ËÖÊÊä³öÖÐÆðÖ÷Òª×÷Óã¬IPЧ¹ûÏÔʾXPO1Äܹ»ÓëRunx2Ö±½ÓÁ¬Ïµ£¬¶øÇõÍXPO1Äܹ»ÔöÌíÒò¹ý±í´ïSIRT6Ëùµ¼ÖµÄRunx2µÄÎȹÌÐÔ½µµÍ¡£½øÒ»²½Ó¦ÓÃXPO1ÒÖÖÆ¼Á£¨Leptomycin A£©ÏÔʾ£¬XPO1ÒÖÖÆ¼ÁÄܹ»ÏÔ׿ÓÖØ¹ý±í´ïSIRT6Ëùµ¼Öµĸƻ¯¼õÇᣬÌáÐÑXPO1ÔÚSIRT6Ëù½éµ¼µÄ¸Æ»¯± £»¤ÖÐÆðµ½Ö÷Òª×÷Óá£

Ê×Ò³|ngµç×ÓÓÎÏ·Öйú¼¯ÍŹٷ½ÍøÕ¾

×ÛÉÏËùÊö£¬¸ÃÎÄÕÂÌá³öÁËSIRT6Äܹ»ÔÚCKDËùÖÂѪ¹Ü¸Æ»¯ÖÐÆð± £»¤×÷Ó㬷¢Ã÷ÁËSIRT6ͨÒÑÍùÒÒõ £»¯Runx2£¬Ôö½øRunx2ͨ¹ýXPO1ÒÀÀµµÄ·½Ê½³öºË£¬½ø¶øÍ¨¹ý·ºËØ-ÂѰ×øϵһÇнµ½âRunx2£¬´Ó¶øÆðµ½½µµÍVSMCsµÄ³É¹Ç·Ö»¯ÓëÒÖÖÆÑª¹Ü¸Æ»¯µÄ×÷Ó᣸ÃÑо¿Õ¹ÏÖÁËCKD»¼Õß±¬·¢Ñª¹Ü¸Æ»¯µÄ¼ÍÂɺÍÓ°ÏìÒòËØ£¬ÆÊÎöÁËSIRT6½éµ¼µÄRunx2·­ÒëºóÐÞÊÎÔÚѪ¹Ü¸Æ»¯ÖеÄ×÷Ó㬲¢½øÒ»²½ÐðÊöÁ˳¤ÊÙÂѰ×SIRT6ÖÎÁÆÑª¹Ü¸Æ»¯µÄÐÂDZÄÜ£¬ÎªÆäÁÙ´²·ÀÖÎÌṩÁËеĸÉÔ¤°ÐµãÓëÕ½ÂÔ¡£

¸ÃÂÛÎĵĵÚÒ»×÷ÕßÊÇngµç×ÓÓÎÏ·Á¥ÊôµÚ°ËÒ½ÔºÀèÎÄÐŲ©Ê¿£¬Á¥ÊôµÚ°ËÒ½Ôº»Æ»Ô½ÌÊÚΪ¸ÃÎÄÕµÄ×ÔÁ¦Í¨Ñ¶×÷Õß¡£¸ÃÑо¿»ñµÃÁ˹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿£¨Åú×¼ºÅ£º8201101103, 81870506, 91849208£¬81670676£©µÈϵÁÐ×ÊÖú¡£Í¬Ê±ÉîÛÚ´óѧÁõ±¦»ª½ÌÊÚ£¬ÄÏ·½Ò½Ôº·ëΰ¾µ£¬ngµç×ÓÓÎÏ·¶«»ªÒ½ÔºËÕÏþÑàºÍngµç×ÓÓÎÏ·Á¥ÊôµÚ°ËÒ½ÔºÂÞ¶¬ÁᣬΪÂÛÎÄ×öÁËÖ÷ҪТ˳¡£

ÂÛÎÄÁ´½Ó£ºhttps://www.jci.org/articles/view/150051

¡¾ÍøÕ¾µØÍ¼¡¿